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Objectives: To evaluate the association between pulmonary restriction and mortality in the el-
derly, taking into account potential confounders not considered in the past (disability, cogni-
tive dysfunction, diabetes, and visceral obesity).
Design: Longitudinal study.
Setting: Community-based.
Participants: Twelve hundred sixty-five patients (51.9% men) aged 65e97 years old from the
Salute Respiratoria nell’Anziano (SaRA) Italian multicentric study.
Measurements: Participants were divided in 4 groups: normal spirometry (NS): FEV1/
FVC 70%, FVC 80% of predicted; restrictive ventilatory pattern (RVP): FEV1/FVC 70%,
FVC< 80%; obstructive ventilatory pattern (OVP): FEV1/FVC< 70%, FVC 80%, and mixed
ventilatory pattern (MVP): FEV1/FVC< 70%, FVC< 80%. We calculated the association be-
tween restriction and mortality corrected for potential confounders using a multivariable
Cox regression model.
Results: We found a prevalence of RVP, OVP and MVP of 10.9%, 25.4%, and 17.3%, respectively.
Compared to people with normal spirometric pattern, disability (19.6% vs. 10.1%), poor phys-
ical performance (35.4% vs. 22.3%), cognitive impairment (21.0% vs. 11.5%), increased waist
circumference (62.1% and 26.8%), and kyphoscoliosis (56.8 and 13.5%) were more prevalent
in the RVP group. After correction for potential confounders, RVP was associated with
increased mortality (HR: 1.89; 95% CI: 1.15e3.11), as well as OVP (HR: 2.33; 95% CI: 1.58e
3.11) and MVP (HR: 2.60; 95% CI: 1.74e3.93). Other factors associated with mortality were dis-
ability (HR: 1.92; 95% CI: 1.35e2.72), poor physical performance (HR: 1.37; 95% CI: 1.01e1.85),22541654; fax: þ39 0622541602.
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1350 S. Scarlata et al.cognitive impairment (HR: 1.55; 95% CI: 1.06e2.27), depression (HR: 1.57; 95% CI: 1.16e2.13)
and diagnosis of stroke (HR: 1.90; 95% CI: 1.18e3.05).
Conclusions: RVP is associated with higher mortality in the elderly and, thus, deserves the
same attention paid to an obstructive pattern. However, mechanisms mediating this associa-
tion need to be clarified.
ª 2008 Elsevier Ltd. All rights reserved.Introduction
Lung restriction is a multi-factorial clinical condition fea-
tured by a reduction of lung volumes. Its estimated
prevalence is 6% in the overall adult and up to 15% in the
elderly population.1,2 The diagnosis of pulmonary restriction
requires the measurement of lung volumes, but a reduction
of the forced ventilatory capacity without bronchial ob-
struction at simple spirometry is commonly used as a proxy
for this condition. This restrictive ventilatory pattern (RVP)
has been associated with mortality in the NHANES I popula-
tion, with adjusted hazard ratios ranging from 1.43 to 1.7,4
depending on different analytic approaches. Similar results
were found in the Atherosclerosis Risk in Communities
(ARIC) study5 and Cardiovascular Health Study (CHS).6
Elderly people have been excluded from the studies per-
formed using NHANES (maximum age: 75 years, with only
3% if the sample aged over 70 years) and ARIC (maximum
age: 66 years) data; therefore, the only information on
elderly people comes from the CHS study, which did not in-
clude people aged less than 65 years. The focus of the pub-
lished study,6 however, was on the association between
decline of pulmonary function and mortality, and data rela-
tive to people with RVP were provided separately for rapid
and non-rapid decliners. Furthermore, this study selected
the subsample of participants who had spirometry per-
formed at both baseline and follow-up (approximately 4
years later); as a consequence, 32% of the baseline popula-
tion was excluded, and the risk of being excluded increased
with age.
Given the lack of information about the prognosis
associated with RVP in the elderly population, we used
the data coming from the Respiratory Health in the Elderly
(Salute Respiratoria nell’Anziano e SARA) study to estimate
the risk of mortality associated with this pattern compared
with normal and pathologic spirometry in a population aged
65 years and older.
Methods
Data source
Between January 1996 and July 1999 a total of 1970
outpatients were recruited from 24 departments of geriat-
rics or respiratory medicine participating in the Respiratory
Health in the Elderly (Salute Respiratoria nell’Anziano e
SARA) study. This is a multi-centre Italian project, investi-
gating various aspects of chronic airway diseases in the
elderly population (age 65 years) affected by pulmonary
and non-pulmonary diseases. Details on the recruitment
criteria, studied population and diagnostic procedures are
available elsewhere.7 The study design was approved bythe Ethical Committees of the participating institutions.
Patients gave their written consent to participate in the
study.
Clinical assessment
Physical functioning was explored using the six-minute walk
test (60 WT) and the Barthel index, cognitive function using
the Mini-Mental Status Examination (MMSE), andmood status
using the 15-item Geriatric Depression Scale (GDS). Patients
underwent a complete physical examination. Co-morbid
diseases, identified on the basis of history and physical
examination, were recorded according to the ICD9. Asthma
was diagnosed according to previously reported criteria.8
Respiratory function assessment
All the centres were provided with an identical fully
computerized water-sealed SteadeWells spirometer (Baires
System; Biomedin; Padua, Italy) matching the standards of
the American Thoracic Society recommendations for di-
agnostic spirometry. Baseline and post-bronchodilator spi-
rometry were performed according to the guidelines of the
American Thoracic Society.8 All the centres achieved a high
quality performance in spirometry. Spirometric flowevol-
ume curves were considered acceptable if they had Extrap-
olated Volume (VEXT) <5% of the FVC or 0.150 L. According
to recommendations by ATS, we did not exclude curves
which did not satisfy the repeatability criteria to avoid
the exclusion of data in which an abnormal lung function
causes a greater coefficient of variation than in normal sub-
jects. FVC was measured only on curves with an end expira-
tory phase 1 s with a volume change lower than the
minimal detectable volume of 0.026 L.9
Current guidelines define RVP as a vital capacity below
the lower limit of normal in absence of obstruction.9 The
studies performed so far on this topic, however, have
used a different definition (forced vital capacity [FVC]
< 80% of predicted) based on older guidelines.10 To provide
results comparable to the available evidence, we decided
to maintain the previous definition and, therefore, defined
RVP on the basis of an FVC< 80% of predicted in absence of
pulmonary obstruction (FEV1/FVC ratio< 0.7). We also in-
cluded in our analysis an obstructive ventilatory pattern
(OVP), defined as a FEV1/FVC ratio< 0.7 with normal
FVC, and a mixed defect (MVP) as the co-existence of
FVC< 80% of predicted and FEV1/FVC ratio< 0.7.
Sample selection and follow-up
From the initial sample we excluded those with incomplete
spirometric data, with spirometries that did not meet the
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throughout January 30, 2002 with regard to their vital
status and cause of death by contacting the registry office
of the last municipality of residence. Information on vital
status was obtained for 1265 of the 1496 patients selected
(84.6%). Follow-up time was calculated from the date of
recruitment (first visit) until the date of death or January
30, 2002, censoring participants if they were still alive at
the end of follow-up or after 60 months. Causes of death
were coded using the 9th revision of the WHO-ICD.
Analytic approach
We compared the demographical and clinical characteris-
tics of people with normal spirometry (NS), RVP, OVP and
MVP, respectively, and evaluated the between-groups
difference using the chi-square test. MMSE and GDS scores
were categorized using a cut-off of 24 and 5, respec-
tively.11,12 We considered physically impaired people who
were not independent in at least 1 activity of daily living
(corresponding to a Barthel’s score< 90), and used the
25th percentile to categorize the distance walked in
6 min (cut-off value: 57% of predicted, corresponding to
an average of 229.6 meters). Smoking status was defined
as former, current or non-smoker. The following factors
expected to be related to both pulmonary restriction and
mortality were included in the analyses: undernutrition
(BMI< 20) and overweight (BMI> 30); visceral obesity
(waist circumference >100 cm in men and >90 cm in
women)13; spine deformities, as reflected by an occiput-Table 1 Demographic, clinical and anthropometric characterist
Respiratory pattern
Normal
(586) %
Restrictive (138) %
(OR; 95% CI)
Age over 80 18.1 (1.00) 26.8 (1.66; 1.08e2.55
Gender (male) 35.8 (1.00) 49.3 (1.74; 1.20e2.53
Smoking status
Never 55.1 (1.00) 58.4 (1.14; 0.78e1.67
Former 32.4 (1.00) 34.1 (1.09; 0.73e1.61
Current 12.5 (1.00) 7.3 (0.55; 0.27e1.10
Disability in at least 1 ADL 10.1 (1.00) 19.6 (2.17; 1.32e3.58
Poor physical performancea 21.4 (1.00) 32.3 (1.75; 1.15e2.67
Cognitive impairmentb 11.5 (1.00) 21.0 (2.05; 1.27e3.32
Depressionc 35.1 (1.00) 36.9 (1.08; 0.73e1.60
Body mass index< 20 3.8 (1.00) 5.1 (1.37;0.57e3.27)
Body mass index >30 18.6 (1.00) 23.9 (1.37; 0.88e2.14
Increased waist
circumferenced
56.8 (1.00) 62.1 (1.24; 0.84e1.83
Spine kyphosise 21.1 (1.00) 39.0 (2.40; 1.58e3.64
Ischemic stroke 5.3 (1.00) 8.8 (1.71; 0.85e3.41
Heart disease 10.8 (1.00) 15.3 (1.49; 0.87e2.54
Diabetes mellitus 11.9 (1.00) 18.2 (1.66; 1.00e2.74
Asthma 5.5 (1.00) 21.0 (4.61; 2.68e7.93
a Six-minute walk distance< 25th percentile (57% of predicted).
b Mini-Mental State Examination score< 24.
c Geriatric depression scale 5.
d Waist circumference 90 (women) or 100 (men).
e Occiput-wall distance> 75th percentile (8 cm).wall distance (OWD) greater than the 75th percentile
(8 cm); selected active diseases (asthma, respiratory dis-
eases, diabetes mellitus, heart disease, ischemic stroke
history).
We compared the mortality rates of people with RVP
relative to controls and other spirometric ventilatory
patterns. To evaluate the association between ventilatory
pattern and mortality taking into account potential con-
founders, we used a multivariable Cox proportional hazard
model. The proportional hazard assumption was checked
using a plot of the log-log of the survival function vs. the log
of follow-up time. We selected the variables to be included
in the model on the basis of clinical judgement as well as
the results of the univariable analysis. People with asthma
are likely to show a RVP,14 but they are functionally to be
considered obstructed, not restricted. Since we felt that
analytic adjustment for the diagnosis of asthma might not
be sufficient to eliminate this possible confounding, we re-
peated the analysis in people without asthma.
All analyses were performed using the SAS for Windows
V9.0 (SAS Institute, Cary, NC).
Results
We studied 1265 patients aged 65e97 years (mean age 73.4;
SD 6.21), men were 51.8%. Of these, 138 (10.9%) showed
a RVP, 322 (25.4%) had an OVP and 219 (17.3%) had MVP.
Socio-demographic and clinical characteristics are shown in
Table 1. The prevalence of people aged 80 years or
older was 26.8% in the group with RVP (OR 1.65; 95% CI:ics
Obstructive (322) %
(OR; 95% CI)
Mixed (219) %
(OR; 95% CI)
P
) 18.6 (1.03; 0.73e1.47) 17.8 (0.98; 0.65e1.47) 0.11
) 65.2 (3.36; 2.52e4.46) 76.3 (5.75; 4.03e8.19) <0.001
) 27.4 (0.30; 0.23e0.42) 23.7 (0.25; 0.17e0.36) <0.001
) 52.2 (2.29; 1.72e3.04) 63.0 (3.55; 2.53e4.98) <0.001
) 20.2 (1.78; 1.23e2.58) 13.2 (1.07; 0.68e1.70) <0.001
) 12.1 (1.23; 0.80e1.89) 24.7 (2.92; 1.94e4.40) <0.001
) 24.3 (1.18;0.85e1.65) 36.0 (2.06; 1.45e2.93) <0.001
) 10.6 (0.91; 0.59e1.41) 15.2 (1.38; 0.88e2.17) 0.009
) 30.2 (0.80; 0.59e1.08) 41.4 (1.31; 0.94e1.80) 0.068
5.0 (1.34;0.69e2.59) 5.9 (1.62; 0.80e3.27) 0.570
) 15.5 (0.80; 0.56e1.16) 16.9 (0.89; 0.59e1.34) 0.180
) 44.1 (0.60; 0.45e0.79) 51.2 (0.80; 0.58e1.09) <0.001
) 32.3 (1.79; 1.30e2.47) 40.7 (2.57; 1.81e3.66) <0.001
) 2.2 (0.40; 0.17e0.92) 4.6 (0.85; 0.41e1.77) 0.020
) 12.3 (1.16; 0.76e1.77) 16.5 (1.63; 1.05e2.54) 0.130
) 10.4 (0.87; 0.56e1.34) 14.7 (1.28; 0.81e2.01) 0.090
) 19.9 (4.29; 2.74e6.73) 26.5 (6.24; 3.91e9.94) <0.001
Figure 1 Survival of people with normal, restrictive, ob-
structive and mixed spirometric pattern.
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among people with NS, airways obstruction and mixed de-
fect (PZ 0.11); men were more prevalent in pathologic
ventilatory patterns compared to NS. Smoking was associ-
ated with OVP, but not with RVP. In RVP and MVP, but not
in the OVP groups, we found a higher prevalence of disabil-
ity and poor physical performance. Cognitive impairment
was more frequent in RVP, as well as a history of stroke
and diabetes. No significant differences were found among
groups with regard to BMI indexes or visceral obesity. The
prevalence of asthma was similar in the RVP, OVP and
MVP groups (21.0%, 19.9%, 26.5%, respectively, PZ
0.179); as expected, the prevalence in the NS group was
markedly lower (5.5%).
We observed 253 deaths during a mean of 53.2 months
follow-up (range: 1e60, cumulative: 5,613 years), yielding
an estimated mortality rate (MR) of 4.51 deaths/100
persons/year, with higher rates in the group with RVP (34
deaths; MR: 5.95 deaths/100 persons/year), OVP (80 deaths;
MR: 5.69 deaths/100 persons/year) and MVP (78 deaths; MR:
8.65 deaths/100 persons/year) vs. 2.23 deaths/100 persons/
year in the NS group. The KaplaneMeier estimators of the
survival function in the different groups are shown in Fig. 1.
Compared to controls the unadjusted hazard ratios (HR) for
death relative to RVP, OVP, and MVP were 2.70 (95% CI:
1.78e4.11), 2.57 (95% CI: 1.84e3.59), and 3.96 (95% CI:
2.83e5.53) respectively. The age- and sex-adjusted HR
was 2.19 (95% CI: 1.44e3.35) in the RVP group, 2.12 (95%Table 2 Cause-specific mortality rates among groups
Respiratory pattern
Normal (/100 PY) Restrictive (/100 PY)
(MRRa; 95% CI)
Cardiac 0.69 (1.00) 1.05 (1.51; 0.60e3.78
Pulmonary 0.07 (1.00) 1.05 (14.36; 2.89e71.
Cerebrovascular 0.22 (1.00) 1.05 (4.79; 1.54e14.8
Neoplasms 0.58 (1.00) 0.52 (0.90; 0.26e3.08
a Mortality rate ratio.CI: 1.52e2.99) in the OVP, 3.42 (95% CI: 2.41e4.85) in the
MVP group.
Table 2 shows the cause-specific mortality rates. Com-
pared to the NS group, those with RVP had an increased
mortality by cerebrovascular causes (mortality rate ratio
[MRR]: 4.79; 95% CI: 1.28e17.91). As expected, mortality
by cardiac and pulmonary diseases was higher in all groups
compared to normal controls. In the RVP group, however,
the mortality rate for pulmonary causes was heavily influ-
enced by the higher prevalence of people with asthma in
this group: when we repeated the analysis excluding people
with asthma, total mortality in this group remained un-
changed (5.7/100 persons/year), while pulmonary mortal-
ity fell to 0.44/100 persons/year. In the OVP and MVP
groups, exclusion of people with asthma changed the esti-
mated pulmonary mortality rate to a much lesser degree
(0.53/100 persons/year and 1.68/100 persons/year, respec-
tively). Finally, mortality for neoplasm was increased in
OVP (MMR: 2.79; 95% CI: 1.41e5.66) and MVP (MMR: 3.22;
95% CI: 1.53e6.81) but not in RVP (MMR: 0.90; 95% CI:
0.17e3.13).
After correction for potential confounders (Table 3),
a RVP was still associated with an increased mortality
(HR: 1.89; 95% CI: 1.15e3.11), as well as OVP (HR: 2.33;
95% CI: 1.59e3.42) and MVP (HR: 2.61; 95% CI: 1.74e
3.93). Other factors associated with mortality were age
over 80 years (HR: 2.52; 95% CI: 1.85e3.43), male sex
(HR: 2.12; 95% CI: 1.42e3.16), current smoking (HR: 2.01;
95% CI: 1.29e3.14), disability (HR: 1.92; 95% CI: 1.35e
2.72), physical limitation (HR: 1.37; 95% CI: 1.01e1.85),
cognitive impairment (HR: 1.55; 95% CI: 1.06e2.27), de-
pression (HR: 1.57; 95% CI: 1.16e2.13) and a diagnosis of
stroke (HR: 1.90; 95% CI: 1.18e3.05). When the analysis
was repeated after exclusion of people with asthma
(NZ 183), the point estimate of association between re-
striction and mortality was unchanged (HR: 1.89; 95% CI:
1.09e3.26), and also confirmed the association of mortality
with OVP (HR: 2.33; 95% CI: 1.59e3.42) and MVP (HR: 2.62;
95% CI: 1.74e3.93).
Discussion
We found that a RVP at spirometry is associatedwith a higher
mortality in elderly people. To our knowledge, this is the
first report on the prognostic value of spirometric restriction
in this age group that takes into account important con-
founders, such as cognitive function, objectively measured
physical performance, and visceral obesity. Our pointObstructive (/100 PY)
(MRRa; 95% CI)
Mixed (/100 PY)
(MRRa; 95% CI)
) 1.71 (2.45; 1.35e4.48) 2.77 (3.98; 2.19e7.23)
16) 0.71 (9.72; 2.13e44.36) 1.66 (21.72; 5.19e49.37)
4) 0.28 (1.30; 0.36e4.59) 0.22 (1.01; 0.20e5.00)
) 1.63 (2.79; 1.47e5.29) 1.88 (3.22; 1.62e6.37)
Table 3 Multivariable Cox regression analysis for 5-years
mortality rates
Hazard
ratio
95% Hazard ratio
confidence limits
Restrictive respiratory pattern 1.89 1.15e3.11
Obstructive respiratory pattern 2.33 1.58e3.42
Mixed respiratory pattern 2.60 1.74e3.93
Age over 80 2.52 1.85e3.43
Male gender 2.17 1.42e3.16
Current smoker 2.01 1.29e3.13
Former smoker 1.12 0.76e1.66
Disability in at least 1 ADL 1.92 1.35e2.72
Poor physical performancea 1.37 1.01e1.85
Cognitive impairmentb 1.55 1.06e2.27
Depressionc 1.57 1.16e2.13
Increased waist circumferenced 0.85 0.64e1.13
Spine kyphosise 0.93 0.67e1.29
Diagnosis of ischemic stroke 1.90 1.18e3.05
Diagnosis of diabetes 1.32 0.92e1.90
Diagnosis of asthma 0.86 0.57e1.28
a Six-minute walk distance< 25th percentile (59% of
predicted).
b Mini-Mental State Examination score< 24.
c Geriatric depression scale 5.
d Waist circumference 90 (women) or 100 (men).
e Occiput-wall distance> 75th percentile (7 cm).
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similar to the one reported by Mannino et al. in the NHANES
population aged less than 75 years (HR: 1.70),4 indicating
that age does not influence the prognostic value of
restriction.
We are not able to directly compare our results with
those coming from the Cardiovascular Health Study, which
included people with an age distribution (mean age: 77
years) similar to the one of the present study, because the
hazard rate estimates of people with restriction are re-
ported separately for those with and without rapid pulmo-
nary function decline. Nonetheless, the mortality rate in our
restricted patients is similar to the one reported by the CHS
investigators for the group with restriction and without
rapid decline of the pulmonary function (5.4/100 person/
year).6 We also found similar mortality rates for obstructive
and mixed ventilatory patterns. Compared to people with-
out both restriction and rapid pulmonary decline (1.9/100
person/year), the unadjusted mortality rate ratio was
2.84, once again very close to the hazard ratio that we cal-
culated in our sample (2.87). Our data provide information
beyond those coming from the CHS for several reasons.
First, survival estimation in the CHS was conditional to re-
maining in the study cohort between baseline and follow-
up spirometry, and this condition was met for only 60% of
people with restriction; second, we provide an adjusted
estimate of the hazard ratio for mortality in people with
restriction regardless of the rapidity of decline of their
lung function. Furthermore, we could take into account
potential confounders that have not been considered
before: waist circumference, cognitive status, and an
objectively measured index of physical performance such
as the six-minute walk test.The increased mortality for pulmonary causes in the
MVP group was not confirmed after correction for the
higher prevalence of asthma in this group. People with
asthma are at increased risk of having a RVP pattern
because of air trapping with reduced vital capacity.
Nevertheless, asthma had a comparable prevalence in the
RVP, OVP, and MVP groups, but only in the RVP the strength
of the association with mortality declined noticeably (from
1.05 to 0.44/100 persons/year) in the analysis excluding
asthmatics. The association between asthma and restric-
tion has been also shown in the NHANES population.15 In
a study on post-puberal asthmatic patients, it was found
that the prevalence of RVP was 24%, but only 8% had
a true reduction in lung volumes measured using plethys-
mography.14 Interestingly, both in the CHS and ARIC stud-
ies, restriction was associated with an increased risk for
hospitalization caused by COPD5,6: this might depend
upon the inclusion of people with asthma in the group
with restriction.
The interpretation of the association between RVP and
total mortality, but not mortality by pulmonary causes, is
not straightforward. We could not find in the literature
other studies reporting cause-specific mortality associated
with restriction, and we can only speculate on the causal
link between this respiratory pattern and mortality. We
derived the causes of death from ICD9 codes reported on
death certificates, and this can introduce some misclassi-
fication.14 Another possible explanation is that RVP may be
a risk factor for other diseases, in the same way as COPD is
a risk factor for cardiovascular diseases,16 or that restric-
tion is an early indicator of a disease that was not diag-
nosed yet at the time of spirometry.
We found only a weak association between RVP and
history of cerebrovascular diseases, and no association
between RVP and cardiovascular diseases and diabetes.
This seems to be counterintuitive, because these disorders
have been linked to pulmonary lung volume reduction.17e19
Our point estimates for these association, however, are
similar to the ones found by Mannino et al. in the NHANES
population.3 Therefore, lack of statistical power seems to
be the most likely explanation for this negative finding.
RVP was associated with visceral obesity, but not with
increased BMI. Therefore, in an elderly population, the
measurement of waist circumference should be preferred
or used in addition to the simple BMI estimation to identify
people at risk for ventilatory dysfunction. The recently
proved relationship between insulin resistance, which is
strictly associated with visceral obesity, and RVP supports
this conclusion.20
This study presents some limitations. First, the diagnosis
of restriction was based on FVC and not on total lung
capacity. Thus, we might have overestimated the number
of patients with reduced lung volumes,21 especially those
with air trapping, although the exclusion of people with
bronchial obstruction (FEV1/FVC< 0.7) reduces this possi-
bility. Second, we were unable to identify all causes of re-
striction, some of which are diseases like, thyroid gland
dysfunction or metabolic syndrome, that remain frequently
unrecognized in the elderly.21e23 Third, the causes of death
were derived from the death certificates and not from clin-
ical chart review; this guarantees for an uniform collection
of data, but carries some risk of misclassification.24
1354 S. Scarlata et al.Conclusion
This study has shown that the association between RVP
and mortality described in people aged less than 75 years
is also present in a population of people aged up to 95
years. Research is needed to verify whether a RVP also
predicts an accelerated decline of physical capabilities.
Collecting this information might expand our knowledge of
the indicators of frailty in the elderly, contributing to
define the profile of risk for disability as well as to clarify
the clinical meaning of and, then, the indications to
spirometry in the elderly.
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